Exosens SAS
PAR:EXENS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Exosens SAS
PAR:EXENS
|
FR |
|
C
|
Creative & Innovative System Corp
KOSDAQ:222080
|
KR |
|
Eltel AB
STO:ELTEL
|
SE |
|
Airgain Inc
NASDAQ:AIRG
|
US |
|
Vcplus Ltd
SGX:43E
|
MY |
|
R
|
R&S Group Holding AG
SIX:RSGN
|
CH |
|
Sureserve Group PLC
LSE:SUR
|
UK |
|
E
|
Entra ASA
OSE:ENTRA
|
NO |
|
B
|
Biotoxtech Co Ltd
KOSDAQ:086040
|
KR |
|
L
|
Leader Environmental Technologies Ltd
SGX:LS9
|
SG |
|
L
|
Lepu Scientech Medical Technology Shanghai Co Ltd
HKEX:2291
|
CN |
Wall Street
Price Targets
EXENS Price Targets Summary
Exosens SAS
According to Wall Street analysts, the average 1-year price target for EXENS is 65.31 EUR with a low forecast of 55.55 EUR and a high forecast of 76.13 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EXENS's stock price target?
Price Target
65.31
EUR
According to Wall Street analysts, the average 1-year price target for EXENS is 65.31 EUR with a low forecast of 55.55 EUR and a high forecast of 76.13 EUR.
What is Exosens SAS's Revenue forecast?
Projected CAGR
15%
For the last 3 years the compound annual growth rate for Exosens SAS's revenue is 33%. The projected CAGR for the next 3 years is 15%.
What is Exosens SAS's Operating Income forecast?
Projected CAGR
21%
For the last 3 years the compound annual growth rate for Exosens SAS's operating income is 54%. The projected CAGR for the next 3 years is 21%.
What is Exosens SAS's Net Income forecast?
Projected CAGR
48%
For the last 3 years the compound annual growth rate for Exosens SAS's net income is 56%. The projected CAGR for the next 3 years is 48%.
